While the push to get Americans vaccinated continues across the country, preliminary data has emerged that lab-created monoclonal antibodies could be a treatment for COVID-19.
The Epidemiology and Disease Control Division of the Nepal Ministry of Health and Population confirmed Thursday the first human fatality due to H5N1 avian influenza infection.